Fig. 8
From: Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease
The association between CD19+CD24−CD38hi plasmablasts/plasma cells and disease activity. a and b Correlations of the ratio of CD19+CD24−CD38hi cells/CD19+ B cells and the absolute number of CD19+CD24−CD38hi plasmablasts/plasma cells with IgG4-related Disease Responder Index (IgG4-RD RI) before treatment. c Change of CD19+CD24−CD38hi plasmablasts/plasma cells before and after treatment. d–h Ratios of CD19+CD24−CD38hi cells/CD19+ B cells, absolute number of CD19+CD24−CD38hi plasmablasts/plasma cells, IgG4-RD RI, IgG, and IgG4 before and after treatment. *** P < 0.001, **** P < 0.0001